Haemonetics | HAE - Equity Capital And Reserves


Haemonetics reported $796.32M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Avanos Medical USD 782.1M 3.9M Mar/2026
Baxter International USD 6.04B 86M Mar/2026
Becton, Dickinson and Co. USD 24.13B 1.15B Mar/2026
Boston Scientific USD 25.86B 1.63B Mar/2026
Cerus USD 64.22M 2.76M Dec/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
Fresenius EUR 19.77B 1.14B Dec/2025
Fresenius Medical Care EUR 14.2B 13.95B Mar/2026
Globus Medical USD 4.73B 159.06M Mar/2026
Haemonetics USD 796.32M 115.13M Mar/2026
ICU Medical USD 2.11B 11.9M Mar/2026
Intuitive Surgical USD 17.47B 349.5M Mar/2026
Masimo USD 788.9M 67.7M Mar/2026
Medtronic USD 48.99B 128M Dec/2025
Merit Medical Systems USD 1.63B 42.42M Mar/2026
Neogen USD 2.1B 2.09M Dec/2025
OraSure Technologies USD 313.32M 27.5M Mar/2026
Plus Therapeutics USD 11.96M 7.96M Mar/2026
Quidel USD 1.85B 69.1M Mar/2026
ResMed USD 6.49B 171.03M Mar/2026
STAAR Surgical USD 352.37M 8.18M Mar/2026
Steris USD 7.18B 29.1M Mar/2026
Stryker USD 22.42B 635M Dec/2025
Surmodics USD 111.31M 7.59M Jun/2025
Teleflex USD 3.08B 40.33M Mar/2026
Terumo JPY 1.58T 62.18B Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
US Physical Therapy USD 468.98M 7.46M Mar/2026
Zimmer Biomet Holdings USD 12.68B 16.1M Mar/2026